Options Cafe blog - options trading education and strategies

We like to explore, educate, and share ideas involving options trading. Come along with us on
our journey to demystify the complex yet rewarding world of options trading.

Related To: Ivonescimab FDA Approval

  1. SMMT (Summit) Stock Analysis: Hold at $16 | Binary FDA Bet
    SMMT (Summit) Stock Analysis: Hold at $16 | Binary FDA Bet
    March 16, 2026
    SMMT rated Speculative Hold. Binary FDA bet on ivonescimab — bull case $28-35, bear case $3-5. PDUFA Nov 14, 2026.
    Read More
Prev
1
Next